Lenskart scales testing, delivery and local manufacturing as Titan EyeCare bets on clinical trust (resurfacing a December update)
Resurfacing details from December 2025: Lenskart added 203 net new India stores in H1 FY26, expanded to 431 cities and uses remote eye tests and next-day delivery to widen access. Titan EyeCare, with 871 exclusive stores as of September 2025, is focused on optometrist-led prescription accuracy and omnichannel conversion.
What happened
Lenskart is scaling India eyewear through AI-led site selection, 203 new stores, remote testing, fast delivery and local manufacturing. Titan EyeCare, with 871
Key facts
- Lenskart listed on NSE at Rs 390, 3% below Rs 402 issue price
- Lenskart declined 2.23% in the last month
- Titan gained 0.99% in the last month and 10.85% over one year
- More than 750 million Indians need vision correction
- India eyewear market estimated at $9.2 billion
- Titan estimated the market at around Rs 30,000 crore
- Titan EyeCare share is less than 12%
- Lenskart conducted 9.3 million eye tests in India in H1 FY26
- 46% of Lenskart eye tests were for first-time users
- Lenskart added 203 net new India stores and reached 431 cities
- Titan had 871 exclusive EyeCare stores as of September 2025
- Lenskart offers remote eye testing in more than 500 stores
- Lenskart next-day delivery available in 58 cities
- Lenskart Q2 product margin was 69.2%
- Local frame production offers 35%-40% cost advantage
- Lenskart manufactured nearly 4 million frames in H1 FY26
Why this matters
Prioritize partnerships or acquisitions in tele-optometry, last-mile delivery, lens manufacturing and clinic-grade diagnostic capabilities to close the gap between access, speed and prescription credibility.
What to watch
- Lenskart's store productivity, payback periods and share of orders fulfilled from stores rather than central warehouses.
- Adoption, accuracy outcomes and regulatory treatment of remote eye testing and digital prescription workflows.
- Delivery-time performance and local-manufacturing capacity during peak demand periods.
- Titan EyeCare's same-store sales growth, premium-lens mix, conversion after eye exams and prescription-remake rates.
- Store additions in tier-2 and tier-3 cities, especially whether new locations expand market demand or cannibalize nearby stores.
- Competitive pricing on frames, anti-glare coatings, progressive lenses and bundled eye-test offers.
- Any increase in consumer complaints, medical-professional scrutiny or compliance requirements around refraction and prescription dispensing.
- Lenskart is likely to deepen city-cluster expansion, using new stores as same-day or next-day fulfillment points and increasing localized inventory allocation.
- Lenskart may bundle remote eye tests, home trials, lens upgrades and membership-style repeat-purchase offers to convert convenience into lifetime value.
- Titan EyeCare is likely to sharpen clinical proof points: certified optometrists, prescription guarantees, remake assurance and specialized progressive, pediatric and myopia-management services.
- Titan may selectively accelerate franchise or smaller-format expansion in high-potential tier-2 and tier-3 markets while reserving full-service stores for premium catchments.
- Both players are likely to invest in unified customer records, appointment booking, digital prescription history and cross-channel attribution as online discovery increasingly ends in store.